WO2002003789A3 - Souris transgéniques contenant des disruptions géniques gpcr ciblées - Google Patents

Souris transgéniques contenant des disruptions géniques gpcr ciblées Download PDF

Info

Publication number
WO2002003789A3
WO2002003789A3 PCT/US2001/021498 US0121498W WO0203789A3 WO 2002003789 A3 WO2002003789 A3 WO 2002003789A3 US 0121498 W US0121498 W US 0121498W WO 0203789 A3 WO0203789 A3 WO 0203789A3
Authority
WO
WIPO (PCT)
Prior art keywords
transgenic mice
mice containing
gpcr gene
gene disruptions
containing targeted
Prior art date
Application number
PCT/US2001/021498
Other languages
English (en)
Other versions
WO2002003789A2 (fr
Inventor
Keith D Allen
Thomas J Brennan
Original Assignee
Deltagen Inc
Keith D Allen
Thomas J Brennan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deltagen Inc, Keith D Allen, Thomas J Brennan filed Critical Deltagen Inc
Priority to AU2001271902A priority Critical patent/AU2001271902A1/en
Publication of WO2002003789A2 publication Critical patent/WO2002003789A2/fr
Publication of WO2002003789A3 publication Critical patent/WO2002003789A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des souris transgéniques, ainsi que des compositions et procédés se rapportant à la caractérisation d'une fonction génique. L'invention concerne plus particulièrement des souris transgéniques présentant des mutations dans un gène GPCR cible. De telles souris transgéniques, qui conviennent comme modèles pour des affections, et pour identifier des agents modulant l'expression génique et la fonction génique, conviennent également comme traitements potentiels pour diverses maladies et divers états pathologiques.
PCT/US2001/021498 2000-07-06 2001-07-06 Souris transgéniques contenant des disruptions géniques gpcr ciblées WO2002003789A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001271902A AU2001271902A1 (en) 2000-07-06 2001-07-06 Transgenic mice containing targeted gpcr gene disruptions

Applications Claiming Priority (44)

Application Number Priority Date Filing Date Title
US21625400P 2000-07-06 2000-07-06
US21647500P 2000-07-06 2000-07-06
US21627100P 2000-07-06 2000-07-06
US21625000P 2000-07-06 2000-07-06
US21610800P 2000-07-06 2000-07-06
US21625200P 2000-07-06 2000-07-06
US21625900P 2000-07-06 2000-07-06
US21647300P 2000-07-06 2000-07-06
US21625300P 2000-07-06 2000-07-06
US21626000P 2000-07-06 2000-07-06
US60/216,473 2000-07-06
US60/216,475 2000-07-06
US60/216,252 2000-07-06
US60/216,260 2000-07-06
US60/216,250 2000-07-06
US60/216,259 2000-07-06
US60/216,253 2000-07-06
US60/216,254 2000-07-06
US60/216,108 2000-07-06
US60/216,271 2000-07-06
US21940300P 2000-07-19 2000-07-19
US60/219,403 2000-07-19
US22147300P 2000-07-27 2000-07-27
US22147400P 2000-07-27 2000-07-27
US22148400P 2000-07-27 2000-07-27
US22149000P 2000-07-27 2000-07-27
US22149700P 2000-07-27 2000-07-27
US60/221,473 2000-07-27
US60/221,474 2000-07-27
US60/221,497 2000-07-27
US60/221,484 2000-07-27
US60/221,490 2000-07-27
US22362500P 2000-08-07 2000-08-07
US60/223,625 2000-08-07
US25181500P 2000-12-06 2000-12-06
US60/251,815 2000-12-06
US26213801P 2001-01-16 2001-01-16
US26213701P 2001-01-16 2001-01-16
US60/262,138 2001-01-16
US60/262,137 2001-01-16
US28026401P 2001-03-29 2001-03-29
US60/280,264 2001-03-29
US30092901P 2001-06-26 2001-06-26
US60/300,929 2001-06-26

Publications (2)

Publication Number Publication Date
WO2002003789A2 WO2002003789A2 (fr) 2002-01-17
WO2002003789A3 true WO2002003789A3 (fr) 2003-02-27

Family

ID=27586645

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021498 WO2002003789A2 (fr) 2000-07-06 2001-07-06 Souris transgéniques contenant des disruptions géniques gpcr ciblées

Country Status (2)

Country Link
AU (1) AU2001271902A1 (fr)
WO (1) WO2002003789A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096299A1 (en) * 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
US7419658B2 (en) 2001-07-09 2008-09-02 Euroscreen S.A. Isolated ligand of ChemerinR
US7470772B2 (en) 2001-07-09 2008-12-30 Euroscreen S.A. Antibody that specifically binds to Chemerin receptor ligand precursor
US7858755B2 (en) 2001-07-09 2010-12-28 Euroscreen S.A. Monoclonal antibodies that bind Chemerin polypeptide
US20050037946A1 (en) * 2003-01-13 2005-02-17 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
WO2005106490A1 (fr) * 2004-04-30 2005-11-10 Bayer Healthcare Ag Agents diagnostiques et therapeutiques pour maladies associees au recepteur 1 de type chimiokine (cmklr1)
WO2016137841A1 (fr) * 2015-02-26 2016-09-01 William Paterson University Of New Jersey Souris transgéniques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047316A1 (fr) * 1996-06-10 1997-12-18 Millennium Pharmaceuticals, Inc. Procedes de selection pour des composes utiles dans la regulation du poids corporel
WO1998053071A1 (fr) * 1997-05-23 1998-11-26 Biogen, Inc. Modulateurs de la regeneration tissulaire

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047316A1 (fr) * 1996-06-10 1997-12-18 Millennium Pharmaceuticals, Inc. Procedes de selection pour des composes utiles dans la regulation du poids corporel
WO1998053071A1 (fr) * 1997-05-23 1998-11-26 Biogen, Inc. Modulateurs de la regeneration tissulaire

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
METHNER AXEL ET AL: "A novel G protein-coupled receptor with homology to neuropeptide and chemoattractant receptors expressed during bone development.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 233, no. 2, 1997, pages 336 - 342, XP002204803, ISSN: 0006-291X *
RANE M ET AL: "Activation of mitogen-activated protein kinases by formyl peptide receptors is regulated by the cytoplasmic tail", JOURNAL OF BIOLOGICAL CHEMISTRY., vol. 273, no. 33, 14 August 1998 (1998-08-14), pages 20916 - 20923, XP002204804 *

Also Published As

Publication number Publication date
AU2001271902A1 (en) 2002-01-21
WO2002003789A2 (fr) 2002-01-17

Similar Documents

Publication Publication Date Title
WO2002079440A3 (fr) Souris transgeniques contenant des ruptures du gene gpcr5-1
WO2002079424A3 (fr) SOURIS TRANSGENIQUES CONTENANT DES DISRUPTIONS DE GENES Gβ3GALT2
WO2002046390A3 (fr) Souris transgeniques a disruptions geniques de tyrosine phosphatase rptpb
WO2002079438A3 (fr) Disruptions du gene ogr1, compositions et procedes associes
WO2002079439A3 (fr) Souris transgeniques presentant des disruptions du gene mglur7 du recepteur de glutamate metabotropique
WO2003026395A3 (fr) Disruptions geniques mo54, compositions et procedes correspondants
WO2002003789A3 (fr) Souris transgéniques contenant des disruptions géniques gpcr ciblées
WO2002040662A3 (fr) Souris transgenique contenant des disruptions geniques ciblees
WO2002048345A3 (fr) Souris transgeniques presentant des disruptions geniques du recepteur de glutamate (grik5)
WO2001067855A3 (fr) Souris transgeniques contenant des interruptions de genes ciblees
WO2002045498A3 (fr) Souris transgenique presentant des disruptions geniques ciblees de proteine canal
WO2002001950A3 (fr) Souris transgeniques contenant des interruptions de genes cibles
WO2002048342A3 (fr) Souris transgeniques presentant des interruptions du gene trp6 au niveau du canal ion calcium
WO2002081658A8 (fr) Souris transgeniques comportant des disruptions geniques sur le canal des ions calcium cacnb4
WO2002003793A3 (fr) Souris transgeniques contenant des disruptions genetiques ciblees
WO2002003788A3 (fr) Souris transgeniques contenant des disruptions ciblees du gene de la phosphatase
WO2002079423A3 (fr) Disruptions du recepteur opioide delta, preparations et methodes associes
WO2002037957A3 (fr) Souris transgeniques contenant des disruptions geniques de la proteine kinase de perk
WO2002003787A3 (fr) Souris transgéniques contenant des disruptions géniques ciblées
WO2003026403A3 (fr) Disruptions du gene ctsz, compositions et methodes correspondantes
WO2002079433A3 (fr) Souris transgeniques presentant des disruptions du gene tmem3 de la beta-1,3-n-acetylglucosaminyltransferase
WO2002003791A3 (fr) Souris transgeniques contenant des interruptions de genes
WO2002048346A3 (fr) Souris transgeniques contenant des disruptions geniques d'une proteine a ancrage membranaire specifique du cerveau
WO2002055687A3 (fr) Souris transgeniques presentant des disruptions geniques cibles
WO2002079412A3 (fr) Souris transgenique presentant des disruption geniques dues a la presence d'une enzyme de desubiquitination de type usp3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: JP